Brian D. Finn
Brian D. Finn's purchase track record
How the stock did after each of Brian D. Finn's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/21/2023 | PDYN | $72K | +226.3% | +175.7% | +15.3% |
| 12/12/2023 | PDYN | $66K | +148.7% | +224.4% | +15.8% |
| 3/28/2023 | PDYN | $49K | -24.2% | -74.1% | +7.6% |
| 6/14/2022 | PDYN | $153K | +7.8% | -76.3% | +7.6% |
| 5/13/2022 | PDYN | $189K | -2.4% | -60.1% | -0.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
ScottsMiracle-Gro Appoints CIO Amid Mixed Analyst Views. ScottsMiracle-Gro has named a new Chief Information Officer to support its technology transformation and growth strategy. While Wells Fargo maintained an overweight rating, it lowered its price target to $60, reflecting cautious sentiment. Other analysts remain more optimistic, with the average target price sitting at $74.17. The stock is currently trading near its support level, indicating a period of consolidation following recent volatility.
Transaction History
| PDYN | ▲ Buy | Grant | 15,083 | $0 | 6/8/2026 | View on chart |
| PDYN | ▲ Buy | Grant | 14,819 | $0 | 6/11/2025 | View on chart |
| PDYN | ▲ Buy | Grant | 107,526 | $237K | 10/31/2024 | View on chart |
| PDYN | ▲ Buy | Open Market | 80,000 | $47K | 12/22/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 40,000 | $24K | 12/21/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 16,459 | $11K | 12/15/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 40,000 | $25K | 12/14/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 30,000 | $18K | 12/13/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 20,000 | $12K | 12/12/2023 | View on chart |
| PDYN | ▲ Buy | Grant | 195,059 | $0 | 6/14/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 57,794 | $26K | 3/29/2023 | View on chart |
| PDYN | ▲ Buy | Open Market | 50,000 | $23K | 3/28/2023 | View on chart |
| PDYN | ▼ Sell | Other | 515,153 | $0 | 12/2/2022 | View on chart |
| PDYN | ▼ Sell | Other | 772,730 | $0 | 12/2/2022 | View on chart |
| PDYN | ▼ Sell | Other | 5,672,168 | $0 | 12/2/2022 | View on chart |
| PDYN | ▼ Sell | Other | 565,929 | $0 | 12/2/2022 | View on chart |
| SMG | ▲ Buy | Grant | 658 | $29K | 10/1/2022 | View on chart |
| SMG | ▲ Buy | Grant | 359 | $29K | 7/1/2022 | View on chart |
| PDYN | ▲ Buy | Grant | 57,692 | $0 | 6/29/2022 | View on chart |
| PDYN | ▲ Buy | Open Market | 35,000 | $109K | 6/15/2022 | View on chart |
| PDYN | ▲ Buy | Open Market | 15,000 | $44K | 6/14/2022 | View on chart |
| PDYN | ▲ Buy | Open Market | 20,000 | $76K | 5/16/2022 | View on chart |
| PDYN | ▲ Buy | Open Market | 30,000 | $112K | 5/13/2022 | View on chart |
| PDYN | ▼ Sell | Other | 451,286 | $0 | 4/1/2022 | View on chart |
| SMG | ▲ Buy | Grant | 226 | $29K | 4/1/2022 | View on chart |
| SMG | ▲ Buy | Grant | 217 | $29K | 2/4/2022 | View on chart |
| SMG | ▲ Buy | Option Exercise | 214 | $0 | 2/4/2022 | View on chart |
| SMG | ▲ Buy | Grant | 1,581 | $0 | 2/4/2022 | View on chart |
| SMG | ▲ Buy | Option Exercise | 90 | $0 | 2/1/2022 | View on chart |
| PDYN | ▼ Sell | Gift | 12,500 | $0 | 1/1/2022 | View on chart |
| PDYN | ▲ Buy | Grant | 12,315 | $0 | 12/9/2021 | View on chart |
| SMG | ▲ Buy | Grant | 170 | $25K | 10/1/2021 | View on chart |
| PDYN | ▲ Buy | Grant | 130,000 | $1.3M | 9/24/2021 | View on chart |
| PDYN | ▲ Buy | Grant | 12,500 | $125K | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
PDYN Q2 2026 Earnings Call Transcript Released
Palladyne AI Corp. released the transcript of its Q2 2026 earnings call. Management discussed the quarter’s results and provided updates on revenue trends and future outlook. The discussion adds context for investors reviewing the company’s performance amid its current price near the lower end of its 52‑week range.
PDYN Q2 2026 Earnings Call Transcript Released. Palladyne AI Corp. released the transcript of its Q2 2026 earnings call. Management discussed the quarter’s results and provided updates on revenue trends and future outlook. The discussion adds context for investors reviewing the company’s performance amid its current price near the lower end of its 52‑week range.